Use access key #2 to skip to page content.
$1.80 0.05 (2.86%)
7/18/2008 3:50 PM

Sunesis Pharmaceuticals, Inc. (SNSS)

CAPS Rating:
No stars

The Company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other unmet medical needs.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

SNSS doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

10 Outperforms
7 Underperforms
 

All-Stars

2 Outperforms
4 Underperforms
 

Wall Street

4 Outperforms
0 Underperforms
 

Players bullish on SNSS are also bullish on:

Players bearish on SNSS are also bearish on:

Ticker Tags

Biotechnology (293), Micro Cap (4824)
Suggest a tag

Sunesis Pharmaceuticals, Inc. At A Glance

Current Price: $1.80
Last Trade Time: 7/18/2008 3:50 PM
Open: $1.75
Previous Close: $1.75
Daily Range: $1.70 - $1.85
52-Week Range: $1.00 - $3.89
Volume: 6,482
Market Cap: $60.14M
P/E Ratio: 0.09
Compare Our Special Broker Offers!

Stock Trends

SNSS VS S&P 500 (SPY)

SNSS 12 month chart vs. S&P

News & Discussion Boards

Sorry no news articles available for SNSS.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Players

picks per page. CHANGE

Results 1 - 2 of 2  

Recs

0

 (SNSS)

Avatar motleyjmw (57.74) Submitted: 1/19/07 1:48 PM : Outperform Start Price: $5.00 SNSS Score: -52.26

Biogen Idec is a beneficial owner

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (SNSS)

Avatar theminc (< 20) Submitted: 10/06/06 9:28 PM : Underperform Start Price: $5.00 SNSS Score: 57.47

Early in the IPO. Solid company with a lot of bright minds. Results of clinical trial results will determine level of success.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 2 of 2  

Wall Street

Results 1 - 4 of 4  

picks per page. CHANGE Expand All Pitches

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackEveillard 89.89 09/30/07 09/30/07 Outperform NS $2.31-22.08%-17.39%-4.69 Toggle the visibility of 60-Second Pitch and replies
TrackRodmanRen < 20 01/08/07 01/08/07 Outperform NS $4.65-61.29%-10.48%-50.81
TrackJefferies 89.98 11/10/06 11/10/06 Outperform NS $5.21-65.45%-8.75%-56.70
TrackCollinsStew 44.18 10/27/06 10/27/06 Outperform NS $5.23-65.58%-9.04%-56.54

Results 1 - 4 of 4  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners